Form 8-K - Current report:
SEC Accession No. 0001493152-22-007101
Filing Date
2022-03-17
Accepted
2022-03-17 08:30:39
Documents
40
Period of Report
2022-03-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38852
2 ex99-1.htm EX-99.1 19748
3 ex99-1_001.jpg GRAPHIC 98221
4 ex99-1_002.jpg GRAPHIC 317199
5 ex99-1_003.jpg GRAPHIC 354285
6 ex99-1_004.jpg GRAPHIC 283654
7 ex99-1_005.jpg GRAPHIC 350909
8 ex99-1_006.jpg GRAPHIC 395498
9 ex99-1_007.jpg GRAPHIC 276137
10 ex99-1_008.jpg GRAPHIC 247393
11 ex99-1_009.jpg GRAPHIC 339167
12 ex99-1_010.jpg GRAPHIC 206971
13 ex99-1_011.jpg GRAPHIC 89964
14 ex99-1_012.jpg GRAPHIC 139105
15 ex99-1_013.jpg GRAPHIC 344406
16 ex99-1_014.jpg GRAPHIC 272627
17 ex99-1_015.jpg GRAPHIC 311320
18 ex99-1_016.jpg GRAPHIC 100397
19 ex99-1_017.jpg GRAPHIC 244640
20 ex99-1_018.jpg GRAPHIC 284860
21 ex99-1_019.jpg GRAPHIC 223338
22 ex99-1_020.jpg GRAPHIC 91750
23 ex99-1_021.jpg GRAPHIC 192600
24 ex99-1_022.jpg GRAPHIC 351728
25 ex99-1_023.jpg GRAPHIC 98366
26 ex99-1_024.jpg GRAPHIC 179561
27 ex99-1_025.jpg GRAPHIC 243837
28 ex99-1_026.jpg GRAPHIC 296050
29 ex99-1_027.jpg GRAPHIC 303106
  Complete submission text file 0001493152-22-007101.txt   9374187

Data Files

Seq Description Document Type Size
30 XBRL SCHEMA FILE pcsa-20220317.xsd EX-101.SCH 3078
31 XBRL LABEL FILE pcsa-20220317_lab.xml EX-101.LAB 34476
32 XBRL PRESENTATION FILE pcsa-20220317_pre.xml EX-101.PRE 22625
34 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3620
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 22746865
SIC: 2834 Pharmaceutical Preparations